Prostacyclin as a potent effector of adipose-cell differentiation
about
sameAs
The organization, promoter analysis, and expression of the human PPARgamma geneCombined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersEndogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes.Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase.Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway.Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion.Transcriptional Pathways in cPGI2-Induced Adipocyte Progenitor Activation for Browning.Fatty acid composition as an early determinant of childhood obesityAn emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?Guardian of corpulence: a hypothesis on p53 signaling in the fat cell.Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.The adipocyte: relationships between proliferation and adipose cell differentiation.Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism.Staurosporine rapidly commits 3T3-F442A cells to the formation of adipocytes by activation of GSK-3beta and mobilization of calcium.Control of adipocyte differentiation.Rapamycin inhibits human adipocyte differentiation in primary culture.Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells.Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells.Stimulation of adipose differentiation related protein (ADRP) expression by ibuprofen and indomethacin in adipocyte precursors and in adipocytes.Maternal consumption of fish oil programs reduced adiposity in broiler chicks.Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases.Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes.Down-regulation of microsomal prostaglandin E2 synthase-1 in adipose tissue by high-fat feeding.The effect of supplementing rumen undegradable unsaturated fatty acids on marbling in early-weaned steers.Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?Angiotensin-converting enzyme gene polymorphisms and obesity: an examination of three black populations.Indomethacin enhanced brown fat activity.Neonatal dietary supplementation of arachidonic acid increases prostaglandin levels in adipose tissue but does not promote fat mass development in guinea pigs.
P2860
Q28244071-FCEEC510-C7A5-4F5C-AA24-E54BCF02896FQ33166521-2565FCAA-9394-403C-86D2-D0CB31387B35Q33849477-CA15231E-C482-47A2-B59D-5E9AD95566DCQ34210726-8A1ACE3E-251C-4D35-9AF4-0BE46E922E19Q34579801-AB49E2FE-329E-4F84-8692-9EB5A164F17AQ34684310-35D05AA1-CCF1-4613-92CF-B98C70F87283Q35074218-B102A5D9-EDB4-4815-9DD1-4F360A4BC5E3Q35669789-388F9E64-4383-42F5-A220-8AA6334E31B5Q35960154-452C447D-4B6B-4AE7-9E5E-846534A22C36Q36776587-797B7D07-FD17-4B80-8321-7761C9AEE4BFQ37097174-44C3B2B6-D6D7-43F4-9AA0-CA10440BF562Q37352957-CD958D53-DF1B-449E-AC75-EBB9F78FA649Q37597603-58D1C42D-43FA-4442-AC4B-113EA6E25BEBQ37900035-923E972B-F54F-41E4-B65E-1350E2879284Q39446637-4E5463A3-A82A-4D94-8FA0-DEDA194A2F8BQ39973612-71600D41-50E1-4066-BFC3-DED4A6E9CCB3Q40462294-23C6D52B-326C-47F2-91BC-AA431142AA5CQ40876792-1E6E0BAA-E4CF-4FB0-821C-64D1FD4DEB05Q41070489-8ECDCF98-18A8-4667-8147-85743674DF35Q41151670-7C33B440-39A9-4E4C-8357-15BE898F589EQ41859391-7749E11A-0135-45D9-9A9B-8F5D309EEE10Q42377267-92CCF8B9-8F1A-4590-B20A-51E7207D4B78Q42798108-089932C5-4A05-4431-8D08-EC753DA7CCE1Q42813297-3EA374B9-0B57-4821-A5DC-261D0DBFDDEFQ42831980-BD19F701-DE41-4833-A79D-A742D1E4C895Q43557762-E688176F-FDFC-484A-80C1-0B11D8126957Q44308532-69894E74-E719-4560-A664-56AB35648EC0Q46341756-87AFA8ED-4B7A-45E4-9970-90870A775470Q51244609-645469DF-AD17-4679-BE1B-4C208F7CE636Q51464540-AFE1C595-0A0E-4F63-9545-15FDDBD67DB4
P2860
Prostacyclin as a potent effector of adipose-cell differentiation
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Prostacyclin as a potent effector of adipose-cell differentiation
@ast
Prostacyclin as a potent effector of adipose-cell differentiation
@en
Prostacyclin as a potent effector of adipose-cell differentiation
@nl
type
label
Prostacyclin as a potent effector of adipose-cell differentiation
@ast
Prostacyclin as a potent effector of adipose-cell differentiation
@en
Prostacyclin as a potent effector of adipose-cell differentiation
@nl
prefLabel
Prostacyclin as a potent effector of adipose-cell differentiation
@ast
Prostacyclin as a potent effector of adipose-cell differentiation
@en
Prostacyclin as a potent effector of adipose-cell differentiation
@nl
P2093
P2860
P356
P1433
P1476
Prostacyclin as a potent effector of adipose-cell differentiation
@en
P2093
P2860
P304
P356
10.1042/BJ2570399
P407
P577
1989-01-15T00:00:00Z